• CEO Fenton Markevich on the Importance of 340B

    President and CEO Fenton Markevich was recently featured in 340B Health’s 340B Chronicle, News from the 340B Health PAC. In this highlight, Fenton answered questions pertaining to his personal commitment and RxStrategies’ commitment to the 340B community and the 340B program, as well as the significance of contributing to the 340B Health PAC. Read the… Read more »

  • Ready to Connect at the 340B Coalition Summer Conference!

    RxStrategies is proud to be a Pinnacle Leader Sponsor of the 2017 340B Coalition Summer Conference, July 10-12. Our team will be connecting with industry leaders to gain insight and discuss the latest 340B Program developments during this highly attended conference. RxStrategies’ 340BPlus™ CompliancePlus (Self-Audit Tool), Dashboard Analytics, Contract Pharmacy, Split Billing and Specialty Pharmacy solutions are key to a… Read more »

  • RxStrategies, Inc. Names Skip Devanny Chief Revenue Officer

    BOCA RATON, Fla., October 28, 2015—RxStrategies, Inc. (www.rxstrategies.com) is pleased to announce the appointment of Skip Devanny to the position of Chief Revenue Officer. In this new role, Skip joins the RxStrategies’ senior leadership team and has responsibility for sales and marketing including the delivery of customized 340B pharmacy administration and split billing solutions to the growing 340B marketplace. “I… Read more »